Signet Industries Limited

Industrials — Conglomerates · NSE

₹59.80+₹0.07 (+0.12%)

DalalBaazaar Score

51 / 100

🟡 Moderate

Verdict

CAUTION

Risk

High

Driven by high debt relative to equity, negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with modest growth. Debt is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:09 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Signet Industries Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Signet Industries Limited primarily engages in the merchant trading of various polymer and plastic granules in India. The company operates through Manufacturing, Wind Power Unit, and Trading segments.

IndustryConglomerates

SectorIndustrials

Employees736

Annual revenue₹1,347 Cr

How does it make money?

Turns over ₹1,347 Cr a year. Of every ₹100 of sales, about ₹1 reaches shareholders as profit, with ₹7 left at the operating level before interest, tax and depreciation. Each of its 736 employees supports ₹1.83 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin7.3%

Net margin1.2%

Revenue / employee₹1.83 Cr

Who are its competitors?

The closest listed comparisons in its industry are LARSEN & TOUBRO LTD., SIEMENS LTD, ABB INDIA LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

LARSEN & TOUBRO LTD.P/E 30.1x · ROE 15.2%

SIEMENS LTDP/E 88.8x · ROE 10.5%

ABB INDIA LIMITEDP/E 92.6x · ROE 19.1%

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 27.7%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 6.5% against a peer median of 15.2% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

ROCE27.7%

ROE6.5%

Peer median ROE15.2%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +32% while net margin moved -6% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+32%

Margin effect-6%

DalalBaazaar Score

51/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ Debt/Equity of 1.86x is high — earnings must service borrowings before shareholders see anything
• Current ratio of 1.26 covers short-term liabilities, without much slack
✗ Free cash flow is negative — growth is being funded by borrowing or fresh equity
✗ Interest cover of only 1.4x — little room if profits dip

Quality vs. Valuation

Company Quality

44/ 100

Weak

How good the business is, ignoring the share price entirely.

Valuation

85/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

Optically cheap, but the underlying business scores poorly. Cheap-and-weak is what a value trap looks like from the outside — the low price may be deserved.

Historical Valuation

Current P/E

8.0x

3Y Median

12.1x

40 monthly readings · mean 12.7x · range 8.4x–20.6x

Sector Median

88.8x

median of 3 sector peers

🟢Current valuation is approximately 34% below its 3y median of 12.1x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 91% below the peer median of 88.8x.

vs. its own history

Cheap

12.1x median over 40 months · -34%

vs. sector peers

Cheap

88.8x median of 3 peers · -91%

vs. generic bands

Cheap

Below 15x

P/E (Trailing)

8.0x

P/B

0.75x

EV/EBITDA

6.3x

PEG

1.08

Dividend Yield

0.84%

What's Good / What's Bad

🟢 What's Going Well4

Return on capital is rising
ROCE has improved from 20.8% to 27.7%.
High return on capital employed
ROCE of 27.7% is the mark of a business that converts capital into profit efficiently.
Valuation below its historical average
At 8.0x the stock trades 34% below its own median of 12.1x.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention3

Debt is rising
Total debt is up 50% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Receivables growing faster than sales
Receivables are up 71% against revenue growth of 32% — customers are taking longer to pay.

Red Flags

5 items require attention · 2 high · 3 watch

🔴High leverageFinancial
Debt/Equity of 1.86x — earnings must service borrowings before shareholders see anything.
🔴Thin interest coverageFinancial
Operating profit covers interest only 1.4x — little room if earnings dip.
🟡Debt is increasingFinancial
Total debt is up 50% over 3 years.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹12 Cr in the latest year.
🟡Receivables growing faster than salesFinancial
Receivables up 71% against revenue up 32% — sales are being booked faster than they are collected.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 27.7% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Priced below its own history
The stock trades 34% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 91% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

The debt load needs earnings to hold up
Debt is 4.5x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
Sales are being booked faster than collected
Receivables are up 71% against revenue up 32%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
2 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 5%✓ 7.3%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA falls below 3x✗ 4.5x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
3Free cash flow remains positive✗ -₹12 Cr
Profit that never becomes cash eventually stops being profit.
4Interest cover stays above 3x✗ 1.4x
How much operating profit can fall before interest stops being comfortably covered.
5Revenue growth stays above 7% a year✓ 9.8% CAGR
Latest reported year was 17.9%. The bar is set below the established compounding rate, so ordinary variation does not trip it.

Investment Checklist

6 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 3 neutral · 3 weak

Market Cap

₹176 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

8.0x

Cheap

Cheap against the generic band

P/B Ratio

0.75x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹7.49

Profitable

Profitable on a per-share basis

ROE

6.5%

Weak

Weak capital efficiency

ROCE

27.7%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

1.86x

High

High leverage

Revenue Growth (YoY)

17.9%

Healthy

Healthy top-line growth

Profit Growth (YoY)

3.3%

Modest

Slow profit growth

Dividend Yield

0.84%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹12 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹59.8

Operating Margin

8.3%

Average

Average margins

Net Margin

1.7%

Weak

Very little revenue reaches the bottom line

Current Ratio

1.26

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.17

Defensive

Steadier than the market

52W Range Position

56%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

64.9 / 67.9

Bearish alignment (short < long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

31.0

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹1,018 Cr	₹1,213 Cr	₹1,179 Cr	₹1,347 Cr	+9.8%
EBITDA	₹67 Cr	₹85 Cr	₹85 Cr	₹98 Cr	+13.3%
EBITDA Margin	6.6%	7.0%	7.2%	7.3%	—
PAT (Net Profit)	₹13 Cr	₹15 Cr	₹16 Cr	₹16 Cr	+7.4%
EPS	₹4.31	₹5.12	₹5.19	₹5.36	+7.5%
ROE	6.3%	7.0%	6.7%	6.5%	—
ROCE	20.8%	27.1%	27.3%	27.7%	—
Total Debt	₹293 Cr	₹317 Cr	₹368 Cr	₹438 Cr	+14.4%
Free Cash Flow	₹43 Cr	₹24 Cr	₹12 Cr	-₹12 Cr	—

🟢 Revenue has grown at 9.8% a year over 3 years.

🟢 EBITDA has grown at 13.3% a year over 3 years.

🟡 EBITDA Margin has held roughly flat at 7.3% over 3 years.

🟢 PAT (Net Profit) has grown at 7.4% a year over 3 years.

🟢 EPS has grown at 7.5% a year over 3 years.

🟡 ROE has held roughly flat at 6.5% over 3 years.

🟢 ROCE has risen from 20.8% to 27.7% over 3 years (+7.0 pts).

🔴 Total Debt has grown at 14.4% a year over 3 years.

🔴 Free Cash Flow has turned negative, from ₹43 Cr to -₹12 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹960 Cr

Total Liabilities

₹713 Cr

Total Debt

₹438 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

₹16 Cr

Capex

-₹29 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

77.3%

Corporate Actions

Dividend Rate

₹0.5

Ex-Dividend Date

23 Sept 2026

Peer Comparison

Company	P/E	ROE
LARSEN & TOUBRO LTD.	30.1x	15.2%
SIEMENS LTD	88.8x	10.5%
ABB INDIA LIMITED	92.6x	19.1%

Recent News

2 positive1 mixed3 general

Signet Industries Lower Circuit Today: Price, Data and Peers

Univest, 13 Oct

Signet Industries standalone net profit rises 1066.67% in the June 2026 quarter

Business Standard, 13 AugResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

Signet Industries shareholders approve ₹0.50 dividend, power expansion

scanx.trade, 02 OctCapacity

🟡Mixed / dependsCapacity additions can raise revenue over two to three years, but the capital spend usually pressures free cash flow first. Worth checking whether the capex is funded from operations or from borrowing.

Signet Industries Share Price Forecast to 2030

Univest, 29 Jul

Signet Industries Upper Circuit Today: Price, Data and Peers

Univest, 09 Oct

Signet Industries Q1 Results: Net profit rises 10.7% QoQ to ₹8.05 crore

scanx.trade, 12 AugResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

🟡Business QualityAdequate12.4/20

🔴Financial HealthStretched5.8/20

🟡GrowthModest10.4/20

🔴ProfitabilityWeak4.5/15

🟢ValuationAttractive13.2/15

🟡RiskModerate4.8/10

Cheap, but for a reason

The low price is the whole case here, and the business underneath scores poorly. Cheap-and-weak is what a value trap looks like from the outside — it needs a specific reason the numbers are about to improve, not just the observation that they are low. 2 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓EBITDA margin holds above 5%7.3%
✗Debt / EBITDA falls below 3x4.5x
✗Free cash flow remains positive-₹12 Cr
✗Interest cover stays above 3x1.4x
✓Revenue growth stays above 7% a year9.8% CAGR